Clinical Trial

Novel ROS-scavenging Nanoenzymes for the Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2025 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
There is no standard treatment for radiation dermatitis. In this study, the investigators have designed novel ROS-scavenging nanoenzymes and aim to evaluate their effectiveness in preventing radiation dermatitis in patients with head and neck cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-11.
Status change: Not Yet Recruiting → Recruiting 2025-08-03
Trial Details
NCT Number NCT07064577
Lead Sponsor West China Hospital
Conditions Radiation Dermatitis
Enrollment 30 participants
Start Date 2025-07-15
Primary Completion 2025-09-15 (estimated)
Study Completion 2025-10-15 (estimated)
Updated on ClinicalTrials.gov 2025-08-07